Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kenneth Byrd
Observed names:
KENNETH P. BYRD,
Kenneth P Byrd,
Kenneth P. Byrd
Observed institutions:
WellStar Health System,
University of Kansas,
University of Tennessee Health Science Center,
National and Kapodistrian University of Athens,
Washington University in St. Louis,
The University of Kansas Cancer Center,
West Cancer Center,
University of Kansas Medical Center
show all 8
OpenAlex ID:
A5060650752
Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma
2017
·
KENNETH P. BYRD
, NAMRATHA R. VONTELA
, et al.
·
Anticancer Research
·
15
PDF
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results
2025
·
Matthew J. Wieduwilt
, Jun Yin
, et al.
·
Journal of Clinical Oncology
·
12
PDF
Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analysis
2023
·
Moazzam Shahzad
, Ali Hussain
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
11
Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2)
2024
·
Jessica M. Stempel
, Geoffrey L. Uy
, et al.
·
Blood
·
9
Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma
2016
·
Namratha R Vontela
, Kenneth Byrd
, et al.
·
Blood
·
5
Cryptococcal Neoformans and Varicella Zoster Meningitis in a Patient With Selective Innate Immunodeficiency: A Case Report
2023
·
Sophiya Karki
, Kenneth P Byrd
·
Cureus
·
2
PDF
Acute promyelocytic leukemia: A single institution's experience.
2022
·
Joseph Bennett
, Tara L. Lin
, et al.
·
Journal of Clinical Oncology
·
2
In silico analysis of non-synonymous SNPs (nsSNPs) and outcomes in non-small cell lung cancer (NSCLC) patients (pts) treated with immunotherapy (IT).
2017
·
Kruti Patel
, Matthew K Stein
, et al.
·
Journal of Clinical Oncology
·
2
Characteristics and Outcomes of Patients with DDX41-Mutated Acute Myeloid Leukemia: A Single-Center Experience
2023
·
Jayanshu Jain
, Kenneth P Byrd
, et al.
·
Blood
·
1
PDF
Patient Characteristics, Toxicity, and Response after Real World Administration of Obecabtagene Autoleucel and Brexucabtagene Autoleucel for Relapsed Acute Lymphoblastic Leukemia: A Rocca Analysis
2026
·
Yannis Valtis
, Karamjeet S. Sandhu
, et al.
·
Transplantation and Cellular Therapy
AML-828: Prognostic Impact and Clinical Outcomes of IDH1/IDH2 Mutations in Newly Diagnosed Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax
2025
·
Jayda Esplund
, Sara Leidy
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-828 Prognostic Impact and Clinical Outcomes of IDH1/IDH2 Mutations in Newly Diagnosed Acute Myeloid Leukemia Treated With Hypomethylating Agents and Venetoclax
2025
·
Jayda Esplund
, Sara Leidy
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Clinicopathologic Features of Epithelial Myoepithelial Carcinoma of the Head and Neck: Analysis of Demographics, Clinical Characteristics, and Treatment Modality
2025
·
Kue Tylor Lee
, Bisma Tareen
, et al.
·
Research Square
Pilot Phase II Trial of the Combination of Tagraxofusp with Pacritinib in Patients with Myelofibrosis, Tagpac Study
2024
·
Abdulraheem Yacoub
, Tara L. Lin
, et al.
·
Blood
AML-560 Molecular Features Associated With CNS Disease in Acute Myeloid Leukemia
2024
·
Jesus D. Gonzalez-Lugo
, Nicole Twardowski
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Molecular Features Associated With CNS Disease in Acute Myeloid Leukemia
2024
·
Jesus D. Gonzalez-Lugo
, Nicole Twardowski
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Rare Presentation of Relapsed Acute Myeloid Leukemia Infiltrating Peripheral Nervous System: A Case Report
2024
·
Carine Tabak
, Jorge Kawano-Castillo
, et al.
·
Annals of Case Reports
PDF
Real-World Outcomes with CPX-351 Induction in Adults with Newly Diagnosed Acute Myeloid Leukemia
2023
·
Joseph G Bennett
, Drake Gilmore
, et al.
·
Blood
PDF
MM-523 Outcomes of Secondary Acute Lymphoblastic Leukemia in Multiple Myeloma
2023
·
Priyanka Venkatesh
, Zahra Mahmoudjafari
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-523 Outcomes of Secondary Acute Lymphoblastic Leukemia in Multiple Myeloma
2023
·
Priyanka Venkatesh
, Zahra Mahmoudjafari
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
PDF
Incidence and Characteristics of Central Nervous System Involvement in Adult Acute Myeloid Leukemia Patients
2021
·
Joshua Tatarian
, Heather J Male
, et al.
·
Blood
In silico analysis of DNA damage repair variants in advanced NSCLC patients (pts) to predict response to platinum-based chemotherapy (PBC).
2017
·
Saradasri Karri
, Matthew K Stein
, et al.
·
Journal of Clinical Oncology
Correlation between PD-L1 expression level and clinical benefit in 204 patients across malignancies at a single institution.
2017
·
Kenneth Byrd
, Panduka Nagahawatte
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
23
Citation count:
59
H-index:
5
I10-index:
3
Year
Topic
Type